Market Access What the low impact of Humira biosimilars teaches us about d... Almost everyone seems to agree that drug prices are too high.
Sales & Marketing Is the pharma industry particularly vulnerable to inflation? The pharma industry is often thought of as one that does not struggle in difficult economic periods – even when times are hard, everyone still values their health.
News Sanofi cuts price of Lantus insulin in US by 78% Pharma joins Eli Lilly, Novo Nordisk as it slashes the price of its widely-prescribed insulins.
News US imposes first rebates on drugs with price hikes Manufacturers will have to pay or face fines on drugs whose prices rose ahead of inflation.
News Novo Nordisk shadows Lilly with insulin price cut plan Danish drugmaker says it will reduce the price of its insulin products in the US by up to 75%.
Sales & Marketing Balancing interests in launching medicines Launching new medicine at the right price is a complex issue, requiring a balance of interests
News Dexcom is first to join FDA/CMS health tech pilot The FDA has named Dexcom as the first company to take part in its TEMPO pilot, which aims to bring digital health tech to patients more quickly.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
